Research and Markets has announced the addition of the "Peripheral Neuropathy Pipeline Highlights - 2017" drug pipelines to their offering.

This report, Peripheral Neuropathy Pipeline Highlights - 2017, provides most up-to-date information on key pipeline products in the global Peripheral Neuropathy market. It covers emerging therapies for Peripheral Neuropathy in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Peripheral Neuropathy pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Peripheral Neuropathy pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Peripheral Neuropathy pipeline products by the company.

Short-term Launch Highlights:

Find out which Peripheral Neuropathy pipeline products will be launched in the US and Ex-US till 2020.

Summary:

  • Peripheral Neuropathy phase 3 clinical trial pipeline products
  • Peripheral Neuropathy phase 2 clinical trial pipeline products
  • Peripheral Neuropathy phase 1 clinical trial pipeline products
  • Peripheral Neuropathy preclinical research pipeline products
  • Peripheral Neuropathy discovery stage pipeline products
  • Peripheral Neuropathy pipeline products short-term launch highlights

Key Topics Covered:

1. Peripheral Neuropathy Pipeline by Stages

2. Peripheral Neuropathy Pipeline by Drug Class

3. Peripheral Neuropathy Pipeline by Company

4. Peripheral Neuropathy Phase 3 Clinical Trial Insights

5. Peripheral Neuropathy Phase 2 Clinical Trial Insights

6. Peripheral Neuropathy Phase 1 Clinical Trial Insights

7. Peripheral Neuropathy Preclinical Research Insights

8. Peripheral Neuropathy Discovery Stage Insights

9. Appendix

10. Research Methodology

For more information about this drug pipelines report visit http://www.researchandmarkets.com/research/2wfcbk/peripheral